Bracco pushes for use of PET-based rubidium for heart scans

10/11/2009 | Diagnostic Imaging

Bracco Diagnostics is actively promoting the use of positron-based rubidium for heart scans as an alternative to the use of gamma-based technetium, which is currently in short supply. Bracco's CardioGen-82 generator of rubidium isotopes is the only available product for generator-based PET myocardial perfusion imaging approved by the FDA. The company said it can supply enough CardioGen-82 to address the demand for clinical cardiac scans during the ongoing shortage.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA